Download PDF
Synthesis 2007(10): 1547-1553  
DOI: 10.1055/s-2007-966037
PAPER
© Georg Thieme Verlag Stuttgart · New York

A New Approach to the Synthesis of the Nonpeptide NOP Receptor Antagonist J-113397

Agnieszka Sulima, John Folk, Arthur E. Jacobson, Kenner C. Rice*
Drug Design and Synthesis Section, Chemical Biology Research Branch, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-0815, USA
Fax: +1(301)020589; e-Mail: kr21f@nih.gov;
Further Information

Publication History

Received 18 January 2007
Publication Date:
02 May 2007 (online)

    Permissions and Reprints All articles of this category

Abstract

A new synthesis that eliminates the need for chromatographic separation in order to obtain multigram quantities of J-113397, a competitive antagonist of the N/OFQ-NOP receptor system, is reported. N-Benzyl protected 4-oxopiperidinecarboxylate was used as the starting material to obtain an N-benzyl intermediate that could be resolved at a relatively early stage in the synthesis. The crucial step in the synthesis was reduction of the double bond of the β-enaminoester functionality of 1-benzyl-4-(3-ethyl-2-oxo-2,3-dihydrobenzoimidazol-1-yl)-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester, since Pd/C reduction gave inseparable mixtures. It could be reduced and epimerized to the desired trans diastere­oisomer in a one-pot reaction by treatment with magnesium metal in methanol.

Key words

NOP antagonist - receptor - synthesis - enantiomeric resolution­ - β-enaminoester reduction

    References

  • 1a Bunzow JR. Saez C. Mortrud M. Bouvier C. Williams JT. Low M. Grandy DK. FEBS Lett.  1994,  347:  284 
    CrossrefPubMedGoogle Scholar
  • 1b Fukuda K. Kato S. Mori K. Nishi M. Takeshima H. Iwabe N. Miyata T. Houtani T. Sugimoto T. FEBS Lett.  1994,  343:  42 
    CrossrefPubMedGoogle Scholar
  • 1c Mollereau C. Parmentier M. Mailleux P. Butour JL. Moisand C. Chalon P. Caput D. Vassart G. Meunier JC. FEBS Lett.  1994,  341:  33 
    CrossrefPubMedGoogle Scholar
  • 1d Nishi M. Takeshima H. Mori M. Nakagawara K. Takeuchi T. Biochem. Biophys. Res. Commun.  1994,  205:  1353 
    CrossrefPubMedGoogle Scholar
  • 1e Wang JB. Johnson PS. Imai Y. Persico AM. Ozenberger BA. Eppler CM. Uhl GR. FEBS Lett.  1994,  348:  75 
    CrossrefPubMedGoogle Scholar
  • 2 Meunier JC. Mollereau C. Toll L. Suaudeau C. Moisand C. Alvinerie P. Butour JL. Guillemot JC. Ferrara P. Monsarrat B. Mazarguil H. Vassart G. Parmentier M. Costentin J. Nature (London)  1995,  377:  532 
    CrossrefGoogle Scholar
  • 3 Reinscheid RK. Nothacker HP. Bourson A. Ardati A. Henningsen RA. Bunzow JR. Grandy DK. Langen H. Monsma FJ. Civelli O. Science  1995,  270:  792 
    CrossrefGoogle Scholar
  • 4 Alexander S. Mathie A. Peters J. MacKenzie G. Smith A. Trends in Pharmacological Science 2001, Nomenclature Supplement  2001,  22 (Suppl. 1):  77 
    Google Scholar
  • 5a Meunier J.-C. Eur. J. Pharmacol.  1997,  340:  1 
    Google Scholar
  • 5b Calo G. Guerrini R. Rizzi A. Salvadori S. Regoli D. Br. J. Pharmacol.  2000,  129:  1261 
    Google Scholar
  • 5c Zeilhofer HU. Calo G. J. Pharmacol. Exp. Ther.  2003,  306:  423 
    Google Scholar
  • 5d Chung S. Pohl S. Zeng J. Civelli O. Reinscheid RK. J. Pharmacol. Exp. Ther.  2006,  318:  262 
    Google Scholar
  • 5e Gavioli EC. Calo G. Naunyn-Schmiedeberg’s Arch. Pharmacol.  2006,  372:  319 
    Google Scholar
  • 6 Zaveri N. Life Sci.  2003,  73:  663 
    CrossrefGoogle Scholar
  • 7a Zaveri N. Jiang F. Olsen C. Polgar W. Toll L. AAPS J.  2005,  7:  E345 
    CrossrefGoogle Scholar
  • 7b Goto Y. Arai-Otsuki S. Tachibana Y. Ichikawa D. Ozaki S. Takahashi H. Iwasawa Y. Okamoto O. Okuda S. Ohta H. Sagara T. J. Med. Chem.  2006,  49:  847 
    CrossrefGoogle Scholar
  • 7c Trapella C. Guerrini R. Piccagli L. Calo G. Carra G. Spagnolo B. Rubini S. Fanton G. Hebbes C. McDonald J. Lambert DG. Regoli D. Salvadori S. Bioorg. Med. Chem.  2006,  14:  692 
    CrossrefGoogle Scholar
  • 8 Wichmann J. Adam G. Rover S. Hennig M. Scalone M. Cesura AM. Dautzenberg FM. Jenck F. Eur. J. Med. Chem.  2000,  35:  839 
    CrossrefGoogle Scholar
  • 9 Kawamoto H. Ozaki S. Itoh Y. Miyaji M. Arai S. Nakashima H. Kato T. Ohta H. Iwasawa Y. J. Med. Chem.  1999,  42:  5061 
    CrossrefPubMedGoogle Scholar
  • 10 Shinkai H. Ito T. Iida T. Kitao Y. Yamada H. Uchida I. J. Med. Chem.  2000,  43:  4667 
    CrossrefGoogle Scholar
  • 11 Ozaki S. Kawamoto H. Itoh Y. Miyaji M. Azuma T. Ichikawa D. Nambu H. Iguchi T. Iwasawa Y. Ohta H. Eur. J. Pharmacol.  2000,  402:  45 
    CrossrefGoogle Scholar
  • 12 Koizumi M. Sakoori K. Midorikawa N. Murphy NP. Br. J. Pharmacol.  2004,  143:  53 
    CrossrefGoogle Scholar
  • 13 Kawamoto H. Nakashima H. Kato T. Arai S. Kamata K. Iwasawa Y. Tetrahedron  2001,  57:  981 
    CrossrefGoogle Scholar
  • 14 De Risi C. Pollini GP. Trapella C. Peretto I. Ronzoni S. Giardina GAM. Bioorg. Med. Chem.  2001,  9:  1871 
    CrossrefGoogle Scholar
  • 15a Hudlicky T. Sinai-Zingde G. Natchus MG. Tetrahedron Lett.  1987,  28:  5287 
    CrossrefGoogle Scholar
  • 15b Ujjainwalla F. Warner D. Snedden C. Grisson RD. Walsh TF. Wyvratt MJ. Kalyani RN. Macneil T. Tang R. Weinberg DH. Van der Ploeg L. Goulet MT. Bioorg. Med. Chem. Lett.  2005,  15:  4023 
    CrossrefGoogle Scholar
  • 16 Caine D. Org. React.  1976,  23:  1 
    Google Scholar
  • 17 Kim H.-O. Carroll B. Lee MS. Synth. Commun.  1997,  27:  2505 
    CrossrefGoogle Scholar
  • 18 Ziegenbein W. Lang W. Chem. Ber.  1960,  93:  2743 
    CrossrefGoogle Scholar
  • 19 Micovic VM. Mihailovic ML. J. Org. Chem.  1953,  18:  1190 
    CrossrefGoogle Scholar